Respiro Diagnostics

Pre-Seed
respirodiagnostics.com Biotech & Healthcare Leeds, United Kingdom
Total Funding $1.3M
Latest Round $1.3M Pre-Seed
Last Announced Jul 8, 2026
Investors Undisclosed
Decision Makers Profile Active

About Respiro Diagnostics

Respiro Diagnostics develops non-invasive breath-based diagnostic tests for early detection of lung cancer and other respiratory diseases.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Pre-Seed
Global Headquarters Leeds, United Kingdom
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website respirodiagnostics.com
Domain Registered Date May 14, 2025

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $1,334,800 · Pre-Seed

    Tech.eu

  2. Milestone

    Website domain registered

    respirodiagnostics.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Respiro Diagnostics.

Funding History

1 Round
Pre-Seed · Jul 8, 2026
$1,334,800 Tech.eu

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts